Predictive ichthyotoxicity, diagnostics and risk assessment of harmful algal blooms impacting on the Tasmanian salmonid aquaculture industry. We aim to define through a combination of laboratory culture exposure and live cage bioassay experiments the minimum cell concentrations of harmful microalgae (Karenia, Heterosigma, Noctiluca, Chaetoceros) that can cause salmonid mortalities or are a factor in compromising fish health or reducing fish farm productivity. The diagnostic pathology and fish be ....Predictive ichthyotoxicity, diagnostics and risk assessment of harmful algal blooms impacting on the Tasmanian salmonid aquaculture industry. We aim to define through a combination of laboratory culture exposure and live cage bioassay experiments the minimum cell concentrations of harmful microalgae (Karenia, Heterosigma, Noctiluca, Chaetoceros) that can cause salmonid mortalities or are a factor in compromising fish health or reducing fish farm productivity. The diagnostic pathology and fish behaviour caused by different harmful algal taxa will be carefully documented to assist fish health inspectors in the routine diagnosis of algal toxicosis ot compromised fish health. Ultimately, this information will be integrated into a risk assessment strategy for the Tasmanian salmonid industry to manage fish stocks during times of harmful algal bloom events.Read moreRead less
A New Platform for Developing a Compound Against Herpes Simplex Virus. This project aims to further explore the research team’s recent fundamental discovery of a protein found naturally in an Australian abalone that inhibits viral entry by blocking three key viral glycoproteins. We would aim to utilise this knowledge towards development of a new class of therapeutics against Herpes simplex viruses (HSV) and their consequent infections. The new therapeutics could overcome the low bioavailability ....A New Platform for Developing a Compound Against Herpes Simplex Virus. This project aims to further explore the research team’s recent fundamental discovery of a protein found naturally in an Australian abalone that inhibits viral entry by blocking three key viral glycoproteins. We would aim to utilise this knowledge towards development of a new class of therapeutics against Herpes simplex viruses (HSV) and their consequent infections. The new therapeutics could overcome the low bioavailability of current drugs and thus significantly shorten the recurrence period. Such new drugs may have broad applicability.Read moreRead less